{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:57:17Z","timestamp":1790690237100,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bprch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.beha.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T07:18:09Z","timestamp":1478330289000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Epidemiology and environmental aspects of marginal zone lymphomas"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4178-8909","authenticated-orcid":false,"given":"Priya","family":"Sriskandarajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Dearden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2016.07.002_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2559.2002.01360.x","article-title":"Marginal zone cell lymphoma \u2013 an update of recent advances","volume":"40","author":"Maes","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.beha.2016.07.002_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","article-title":"Lymphoma development in patients with autoimmune and inflammatory disorders \u2013 what are the driving forces?","volume":"24","author":"Baecklynd","year":"2014","journal-title":"Semin Cancer Biol"},{"issue":"20","key":"10.1016\/j.beha.2016.07.002_bib3","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2016.07.002_bib4","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/01.pas.0000213275.60962.2a","article-title":"The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America","volume":"30","author":"Remsterin","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.beha.2016.07.002_bib5","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A\u00a0clinical evaluation of the international lymphoma study group classification of non-Hodgkin\u2019s lymphoma. The non-Hodgkin\u2019s lymphoma classification project","volume":"89","author":"Perry","year":"1997","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2016.07.002_bib6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrc1409","article-title":"MALT lymphoma: from morphology to molecules","volume":"4","author":"Isaacson","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.beha.2016.07.002_bib7","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients","volume":"95","author":"Berger","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2016.07.002_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.blre.2004.03.002","article-title":"Splenic marginal zone lymphoma","volume":"19","author":"Oscier","year":"2005","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.beha.2016.07.002_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bjh.12730","article-title":"Incidence of marginal zone lymphoma in the United States, 2001\u20132009 with a focus on primary anatomic site","volume":"165","author":"Khalil","year":"2014","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.beha.2016.07.002_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/cncr.27773","article-title":"Survival of patients with marginal zone lymphoma: analysis of the surveillance, epidemiology and end results database","volume":"119","author":"Olszewski","year":"2012","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.beha.2016.07.002_bib11","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1002\/cncr.25325","article-title":"Marginal zone lymphomas: factors that affect the final outcome","volume":"116","author":"Mazloom","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2016.07.002_bib12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"issue":"8797","key":"10.1016\/j.beha.2016.07.002_bib13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0140-6736(92)90280-G","article-title":"High incidence of gastric lymphoma in northeastern Italy","volume":"339","author":"Doglioni","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2016.07.002_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.10332","article-title":"Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-Cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects young patients","volume":"73","author":"Cho","year":"2003","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.beha.2016.07.002_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.beha.2016.07.002_bib16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ajh.20962","article-title":"Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea","volume":"82","author":"Yoo","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2016.07.002_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-122-3-199502010-00002","article-title":"Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes","volume":"122","author":"Pawlotsky","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beha.2016.07.002_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.11893","article-title":"Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles","volume":"100","author":"Arcaini","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2016.07.002_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2141.1994.tb05036.x","article-title":"Hepatitis C virus infection in patients with non-Hodgkin\u2019s lymphoma","volume":"88","author":"Ferri","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2016.07.002_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2169\/internalmedicine.39.112","article-title":"Hepatitis C virus infection in patients with B-cell non-Hodgkin\u2019s lymphoma","volume":"39","author":"Mizorogi","year":"2000","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.beha.2016.07.002_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.20205","article-title":"B-cell non-Hodgkin\u2019s lymphoma and hepatitis C virus infection: a systematic review","volume":"111","author":"Negri","year":"2004","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.beha.2016.07.002_bib22","doi-asserted-by":"crossref","first-page":"e2016006","DOI":"10.4084\/mjhid.2016.006","article-title":"Infectious aetiology of marginal zone lymphoma and role of anti-infective therapy","volume":"8","author":"Perrone","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"2","key":"10.1016\/j.beha.2016.07.002_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","article-title":"Effects of Helicobacter pylori eradication on early stage mucosa-associated lymphoid tissue lymphoma","volume":"8","author":"Zullo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.beha.2016.07.002_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","article-title":"Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan","volume":"61","author":"Nakamura","year":"2012","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.beha.2016.07.002_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.43.5.721","article-title":"Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in the modern era","volume":"43","author":"Blaser","year":"1998","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.beha.2016.07.002_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1172\/JCI20925","article-title":"Helicobacter pylori persistence: biology and disease","volume":"113","author":"Blaser","year":"2004","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1016\/j.beha.2016.07.002_bib27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.beha.2016.07.002_bib28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/IAI.58.3.603-610.1990","article-title":"Characterisation of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity","volume":"58","author":"Cover","year":"1990","journal-title":"Infect Immun"},{"issue":"8763","key":"10.1016\/j.beha.2016.07.002_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0140-6736(91)90477-7","article-title":"Mucosal IgA recognition of Helicobacter pylori 120\u00a0kDa protein, peptic ulceration and gastric pathology","volume":"338","author":"Crabtree","year":"1991","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.beha.2016.07.002_bib30","first-page":"2111","article-title":"Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach","volume":"55","author":"Blaser","year":"1995","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.beha.2016.07.002_bib31","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1038\/bcj.2013.22","article-title":"Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significance","volume":"3","author":"Kuo","year":"2013","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.beha.2016.07.002_bib32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1086\/367807","article-title":"The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa","volume":"187","author":"Yamazaki","year":"2003","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.beha.2016.07.002_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1097-2765(02)00681-0","article-title":"Grb2 is a key mediator of Helicobacter pylori CagA protein activities","volume":"10","author":"Mimuro","year":"2002","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.beha.2016.07.002_bib34","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1074\/jbc.M208155200","article-title":"Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase","volume":"278","author":"Tsutsumi","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.beha.2016.07.002_bib35","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/leu.2010.76","article-title":"B-cell receptor signalling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis","volume":"24","author":"Craig","year":"2010","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.beha.2016.07.002_bib36","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.3748\/wjg.v21.i10.2883","article-title":"To be or not to be: the host genetic factor and beyond in Helicobacter pylori mediated gastro-duodenal diseases","volume":"21","author":"Datta De","year":"2015","journal-title":"World J Gastroentero"},{"issue":"8871","key":"10.1016\/j.beha.2016.07.002_bib37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon","year":"1993","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.beha.2016.07.002_bib38","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3748\/wjg.v16.i17.2158","article-title":"Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma","volume":"16","author":"Park","year":"2010","journal-title":"World J Gastroentero"},{"issue":"10","key":"10.1016\/j.beha.2016.07.002_bib39","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MCG.0b013e318286ff72","article-title":"Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review","volume":"47","author":"Zullo","year":"2013","journal-title":"J\u00a0Clin Gastroentero"},{"key":"10.1016\/j.beha.2016.07.002_bib40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","article-title":"EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT","volume":"60","author":"Ruskone-Fourmestraux","year":"2011","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.beha.2016.07.002_bib41","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00042737-199409000-00004","article-title":"Short-term low-dose triple therapy for the eradication of Helicobacter pylori","volume":"6","author":"Bazzoli","year":"1994","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.beha.2016.07.002_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megrauf","year":"2013","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.beha.2016.07.002_bib43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/CMR.00033-06","article-title":"Helicobacter pylori detection and antimicrobial susceptibility testing","volume":"20","author":"Megraud","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.beha.2016.07.002_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femspd\/ftu007","article-title":"Chlamydia psittaci: update on an underestimated zoonotic agent","volume":"73","author":"Knittler","year":"2015","journal-title":"Pathog Dis"},{"issue":"4","key":"10.1016\/j.beha.2016.07.002_bib45","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/leu.2011.276","article-title":"Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation","volume":"26","author":"Dagklis","year":"2012","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.beha.2016.07.002_bib46","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/CAD.0b013e32830b58c4","article-title":"Variable association between Chlamydophila psittaci infection and ocular adnexal lymphomas: methodological biases or true geographical variations?","volume":"19","author":"Decaudin","year":"2008","journal-title":"Anticancer Drugs"},{"issue":"19","key":"10.1016\/j.beha.2016.07.002_bib47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/djj373","article-title":"Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial","volume":"98","author":"Ferreri","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"24","key":"10.1016\/j.beha.2016.07.002_bib48","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","article-title":"Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial","volume":"30","author":"Ferreri","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.beha.2016.07.002_bib49","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2141.2010.08179.x","article-title":"Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial","volume":"150","author":"Govi","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2016.07.002_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000007256","article-title":"Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer","volume":"46","author":"Hamada","year":"2000","journal-title":"Chemotherapy"},{"key":"10.1016\/j.beha.2016.07.002_bib51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.semcancer.2013.09.004","article-title":"Marginal zone lymphomas and infectious agents","volume":"23P","author":"Ferreri","year":"2013","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"10.1016\/j.beha.2016.07.002_bib52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0190-9622(91)70088-J","article-title":"Borrelia burgdorferi \u2013 associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases","volume":"24","author":"Garbe","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.beha.2016.07.002_bib53","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.0303-6987.2003.00167.x","article-title":"Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic and molecular study of 106 cases","volume":"31","author":"Colli","year":"2004","journal-title":"J\u00a0Cutan Pathol"},{"issue":"8","key":"10.1016\/j.beha.2016.07.002_bib54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1600-0560.1997.tb01318.x","article-title":"Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma","volume":"24","author":"Cerroni","year":"1997","journal-title":"J\u00a0Cutan Pathol"},{"issue":"11","key":"10.1016\/j.beha.2016.07.002_bib55","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1634\/theoncologist.2011-0108","article-title":"Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas","volume":"16","author":"Ponzoni","year":"2011","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.beha.2016.07.002_bib56","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1034\/j.1600-0560.2001.281002.x","article-title":"Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States","volume":"28","author":"Wood","year":"2001","journal-title":"J\u00a0Cutan Pathol"},{"issue":"5","key":"10.1016\/j.beha.2016.07.002_bib57","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00000478-200305000-00017","article-title":"Borrelia-associated primary cutaneous MALT lymphoma in a nonendemic region","volume":"27","author":"de la Fouchardiere","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.beha.2016.07.002_bib58","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","article-title":"Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases","volume":"141","author":"Hoefnagel","year":"2005","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.beha.2016.07.002_bib59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000106580","article-title":"Borrelia burgdorferi \u2013 associated primary cutaneous marginal zone B-cell lymphoma: a case report","volume":"215","author":"Monari","year":"2007","journal-title":"Dermatology"},{"issue":"11","key":"10.1016\/j.beha.2016.07.002_bib60","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1080\/10428190701618250","article-title":"Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association","volume":"48","author":"Goteri","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.beha.2016.07.002_bib61","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.exppara.2007.10.014","article-title":"Prevalence of Cryptosporidium and Giardia species in animals in irrigation catchments in the southwest of Australia","volume":"118","author":"McCarthy","year":"2008","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.beha.2016.07.002_bib62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa031887","article-title":"Immunoproliferative small intestinal disease associated with Campylobacter jejuni","volume":"350","author":"Lecuit","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2016.07.002_bib63","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(77)92816-1","article-title":"Alpha-chain disease: evidence for common clonal origin of intestinal immunoblastic lymphoma and plasmacytic proliferation","volume":"1","author":"Brouet","year":"1977","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.beha.2016.07.002_bib64","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.dld.2012.03.020","article-title":"Immunoproliferative small intestine disease associated with Campylobacter jejuni","volume":"44","author":"Mesnard","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"2\u20133","key":"10.1016\/j.beha.2016.07.002_bib65","first-page":"239","article-title":"Immunoproliferative small intestinal disease (IPSID): relationships with alpha-chain disease and Mediterranean lymphomas","volume":"12","author":"Rambaud","year":"1990","journal-title":"Semin Immunopathol"},{"issue":"1","key":"10.1016\/j.beha.2016.07.002_bib66","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<8::AID-CNCR2>3.0.CO;2-T","article-title":"Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience","volume":"80","author":"Akbulut","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2016.07.002_bib67","article-title":"A\u00a0public health approach to hepatitis C control in low- and middle-income countries","author":"Suthar","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.beha.2016.07.002_bib68","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: syetmatic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.beha.2016.07.002_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin Liver Dis"},{"issue":"51","key":"10.1016\/j.beha.2016.07.002_bib70","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of na\u00efve B lymphocytes via CD81,a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.beha.2016.07.002_bib71","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2141.1996.d01-1791.x","article-title":"Additional neoplasms and HCV infection in low-grade lymphoma of MALT type","volume":"94","author":"Luppi","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2016.07.002_bib72","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/annonc\/mdl388","article-title":"Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT","volume":"18","author":"Arcaini","year":"2007","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.beha.2016.07.002_bib73","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/annonc\/mdl027","article-title":"Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa","volume":"17","author":"Ferreri","year":"2006","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.beha.2016.07.002_bib74","first-page":"80","article-title":"Marginal zone-related neoplasms of splenic and nodal origin","volume":"88","author":"Arcaini","year":"2003","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.beha.2016.07.002_bib75","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V","article-title":"Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy","volume":"77","author":"Mazzaro","year":"1996","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.beha.2016.07.002_bib76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"S4","key":"10.1016\/j.beha.2016.07.002_bib77","first-page":"138","article-title":"Hematological response to antiviral treatment in 94 patients with indolent B-cell lymphomas associated with hepatitis C virus infection: a study of the Fondazione Italiana Linformi (FIL)","volume":"22","author":"Arcaini","year":"2011","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.beha.2016.07.002_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.23889","article-title":"Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS, HC-13 lympho-C study","volume":"90","author":"Michot","year":"2015","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.beha.2016.07.002_bib79","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/cpt.185","article-title":"Direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection: interferon free is now","volume":"98","author":"Florian","year":"2015","journal-title":"Clin Phamacol Ther"},{"issue":"12","key":"10.1016\/j.beha.2016.07.002_bib80","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1002\/cncr.25114","article-title":"Smoking, alcohol use, obesity and overall survival from non-Hodgkin lymphoma: a population-based study","volume":"116","author":"Geyer","year":"2010","journal-title":"Cancer"},{"issue":"48","key":"10.1016\/j.beha.2016.07.002_bib81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","article-title":"Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph non-Hodgkin lymphoma subtypes project","volume":"2014","author":"Morton","year":"2014","journal-title":"J\u00a0Natl Cancer Inst Monogr"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692616300731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T11:11:33Z","timestamp":1718881893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692616300731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":81,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1521692616300731"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2016.07.002","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and environmental aspects of marginal zone lymphomas","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}